25 May 2013
Keywords: chris, brinsmead, named, abpi, president, designate, anglo-swedish
Article | 10 December 2007
Chris Brinsmead, president of Anglo-Swedish drugmaker AstraZeneca in the UK, has been named as president designate of the Association of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 December 2007
24 May 2013
© 2013 thepharmaletter.com